PLSE
PLSE
US74587B1017
Pulse Biosciences, Inc
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
3.84B EUR
1.96B EUR
1.47B EUR
931.44M EUR
Enterprise Value
3.47B EUR
1.87B EUR
1.41B EUR
858.23M EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-45.99x
--
--
--
Price to Sales
3,238.71x
1,656.78x
1,961.36x
2,661.25x
Price to Book
38.3x
19.73x
22.22x
11.55x
EV/Revenue
2,928.15x
1,576.74x
1,879.91x
2,452.1x
EV/EBITDA
-42x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-0.89%
-3.13%
-3.77%
-4.39%
ende